Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Other safety areas under investigation include: Lean muscle mass preservation significant weight loss can result in loss of muscle tissue, and researchers are monitoring body composition changes Bone density a consideration with rapid weight loss in general Thyroid C-cell effects a class concern for GLP-1 receptor agonists, though clinical significance in humans remains uncertain [13] Pancreatitis and gallbladder disease signals observed across the incretin class are being monitored for retatrutide, though no established causal link has been confirmed for this agent specifically Dehydration and kidney function prolonged vomiting or diarrhoea can lead to dehydration and, in some cases, acute kidney injury
44,45 In a meta-analysis of 48 RCTs including 27,729 participants, the overall incidence of GI adverse events was reported to be 11.6%, with nausea identified as the most common symptom (21.4%)
Semaglutide is a well-known GLP-1 medication that has been used for diabetes and weight loss for several years
FIGURE 3 FIGURE 4 (B ) Initial presentation of the persistent gastrocutaneous fistula and BPC 157 therapy effect
